SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Linezolid for treatment of ventilator-associated pneumonia: A cost-effective alternative to vancomycin*
4 references·1 citing·19 second hop
Linezolid for treatment of ventilator-associated pneumonia: A cost-effective alternative to vancomycin* (2004)Linezolid for treatment of ventilator-ass…Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis* (2003)Cost-effectiveness of drotrec…Understanding Costs and Cost-Effectiveness in Critical Care: Report from the Second American Thoracic Society Workshop on Outcomes Research (2002)Understanding Costs and Cost-…Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Recommendations of the Panel …Federal and nationwide intensive care units and healthcare costs: 1986-1992 (1994)Federal and nationwide intens…Cost-Effectiveness Studies in the ICU: A Systematic Review* (2019)Cost-Effectiveness Studies in…How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)The Beaver Dam Health Outcomes study (1993)Cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in Germany (2003)Five-year survival, quality of life, and individual costs of 303 consecutive medical intensive care patients—A cost-utility analysis (2005)When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature* (2006)EuroQol - a new facility for the measurement of health-related quality of life (1990)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)Recommendations for Reporting Cost-effectiveness Analyses (1996)Variations in population health status: results from a United Kingdom national questionnaire survey (1998)Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge? (2004)Methods for the Economic Evaluation of Health Care Programmes (2005)Guidelines for pharmacoeconomic studies. (1992)Guidelines for Pharmacoeconomic Studies (1997)Markov Models in Medical Decision Making (1993)The Role of Cost-effectiveness Analysis in Health and Medicine (1996)Health Economic Methods: Cost-Minimization, Cost-Effectiveness, Cost-Utility, and Cost-Benefit Evaluations (2011)The Critical Care Crisis in the United States (2004)Direct Cost Analysis of Intensive Care Unit Stay in Four European Countries: Applying a Standardized Costing Methodology (2012)Critical Care Medicine Beds, Use, Occupancy, and Costs in the United States (2015)
this work references cited by second hop

References

  • 1996Recommendations of the Panel on Cost-Effectiveness in Health and Medicine2,455 cited
  • 2003Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis*225 cited
  • 1994Federal and nationwide intensive care units and healthcare costs: 1986-1992211 cited
  • 2002Understanding Costs and Cost-Effectiveness in Critical Care: Report from the Second American Thoracic Society Workshop on Outcomes Research147 cited

Cited by

  • 2019Cost-Effectiveness Studies in the ICU: A Systematic Review*64 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work